Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

2381 - 2390 of 3572 results found

Organizational Guideline for Gynecologic Oncology Services in Ontario

MeSH Terms

Organizational Policy (I01.655.500.550); Health Facilities (N02.278); Centralized Hospital Services (N02.278.354.110); Clinical Competence (I02.399.630.210)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2013

Oropharyngeale Dysphagie infolge einer Kopf-Hals-Tumor-Erkrankung – Diagnostik und Therapie. S3-LL (DGPP)

MeSH Terms

Oropharyngeal Neoplasms (C04.588.443.665.710.684); Oropharyngeal Neoplasms (C09.647.710.685); Oropharyngeal Neoplasms (C07.550.745.671); Oropharyngeal Neoplasms (C09.775.549.685)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Oropharyngeal dysphagia secondary to head and neck cancer - diagnosis and therapy
Keywords
Kopf-Hals-Tumore, oropharyngeale Dysphagie, Schluckstörung, Krebserkrankung, onkologische Erkrankung
Date for Review
31/03/2030
Publication Date
07/04/2025
Publication Scope
counselling
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2025

Osteoporoosi

MeSH Terms

Musculoskeletal Diseases (C05); Osteoporosis (C05.116.198.579)

Guideline Contact
Raija Sipilä ([email protected])
English Title Translation
Osteoporosis
Publication Date
8.12.2020, partially updated 6.3.2025
Publication Scope
assessment
management
Countries of Application
Finland
Guideline Publication Status
Published
Languages
Finnish
Authors
CC (FI)
Publication Year
2020

Osteoporosis identification and management in primary care

MeSH Terms
Osteoporosis [C05.116.198.579] ; Osteoporosis, Postmenopausal [C05.116.198.579.610]; Osteoporotic Fractures [C26.404.545]; Bone Density Conservation Agents [D27.505.696.242]Alendronate [D02.705.429.500.100]; Ibandronic Acid [D02.705.429.500.844]; Risedronic Acid [D02.705.429.500.872]; Zoledronic Acid [D02.705.429.500.942]; Denosumab [D12.776.124.486.485.114.224.060.782]; Teriparatide [D06.472.699.590.850]
Guideline Contact
Agency for Care Effectiveness
English Title Translation
NA
Keywords
bone density, osteoporosis, fracture, OSTA, FRAX
Date for Review
07-Nov-23
Publication Date
07-Nov-18
Expected Publication Date
17-Feb-25
Methods Applied
GRADE; AGREE II; RAND/UCLA; Systematic search of guidelines; systematic searches; risk of bias
Publication Scope
assessment
Prevention
Management
Treatment
Countries of Application
Singapore
Guideline Publication Status
Review
Languages
English
Authors
Agency for Care Effectiveness Singapore
Willingness to Collaborate
Yes
Publication Year
2018
Name of Endorsing Organization
Ministry of Health Singapore
My Saved Lists